Your browser doesn't support javascript.
loading
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
McIntyre, Roger S; Calabrese, Joseph R; Nierenberg, Andrew A; Farahmand, Khodayar; Yonan, Chuck; Siegert, Scott; Burke, Joshua.
Afiliação
  • McIntyre RS; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: roger.mcintyre@uhn.ca.
  • Calabrese JR; Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
  • Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, MA, United States.
  • Farahmand K; Neurocrine Biosciences, Inc., San Diego, CA, United States.
  • Yonan C; Neurocrine Biosciences, Inc., San Diego, CA, United States.
  • Siegert S; Neurocrine Biosciences, Inc., San Diego, CA, United States.
  • Burke J; Neurocrine Biosciences, Inc., San Diego, CA, United States.
J Affect Disord ; 246: 217-223, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30583148
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrabenazina / Valina / Transtornos do Humor / Discinesia Tardia Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrabenazina / Valina / Transtornos do Humor / Discinesia Tardia Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article